Ginkgo Bioworks

North America, Massachusetts, United States, Boston

Description

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Investor Profile

Ginkgo Bioworks has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

Series A (57%)
Series Unknown (14%)
Post Ipo Equity (14%)
Seed (14%)

Country Focus

United States (86%)
Israel (14%)

Industry Focus

Biotechnology
Health Care
Renewable Energy
Agriculture
Environmental Consulting
Chemical Engineering
Cleantech
Manufacturing
Therapeutics
Environmental Engineering

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ginkgo Bioworks frequently co-invest with?

Cascade Investment

North America, Colorado, United States, Colorado Springs

Co-Investments: 1

DSM Venturing

Europe, Limburg, The Netherlands, Heerlen

Co-Investments: 1

Casdin Capital

North America, New York, United States, New York

Co-Investments: 1

Cibus Fund

Europe, England, United Kingdom, London

Co-Investments: 1

Agriline

Europe, Worcestershire, United Kingdom, Bromsgrove

Co-Investments: 1

General Atlantic

North America, New York, United States, New York

Co-Investments: 1

Viking Global Investors

North America, Connecticut, United States, Stamford

Co-Investments: 4

Leaps by Bayer

Europe, Nordrhein-Westfalen, Germany, Leverkusen

Co-Investments: 2

Arkin Holdings

Asia, Tel Aviv, Israel, Herzliya

Co-Investments: 1

Battelle

North America, Ohio, United States, Columbus

Co-Investments: 1

Which angels does Ginkgo Bioworks often collaborate with?

Yossi Ackerman

Asia, Israel

Shared Deals: 1

What are some of recent deals done by Ginkgo Bioworks?

Phytolon

Yoqne`am `illit, HaZafon, Israel

Phytolon offers natural food colors in high quality at low costs.

BiotechnologyFood and BeverageOrganic

Series AJul 6, 2022

Amount Raised: $14,500,000

Cambium

Mojave, California, United States

Cambium develops biomaterials for applications across defense, space, aerospace, and renewable energy.

Advanced MaterialsAerospaceLaw EnforcementNational SecurityRenewable Energy

SeedSep 14, 2021

Amount Raised: $8,012,877

Allonnia

Boston, Massachusetts, United States

Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.

BiotechnologyEnvironmental EngineeringMining TechnologyWaste Management

Series AOct 22, 2020

Amount Raised: $40,000,000

Synlogic

Cambridge, Massachusetts, United States

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

BiotechnologyHealth CareTherapeutics

Post Ipo EquityJun 12, 2019

Amount Raised: $80,000,000

Genomatica

San Diego, California, United States

Genomatica manufactures sustainable chemicals from renewable feedstocks.

Chemical EngineeringCleanTechManufacturingRenewable Energy

Series UnknownOct 3, 2018

Amount Raised: $90,000,000

Joyn Bio

Boston, Massachusetts, United States

A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.

AgricultureBiotechnologyEnvironmental ConsultingHealth Care

Series AMar 20, 2018

Amount Raised: $100,000,000

Joyn Bio

Boston, Massachusetts, United States

A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.

AgricultureBiotechnologyEnvironmental ConsultingHealth Care

Series ASep 14, 2017

Amount Raised: $100,000,000

Ginkgo Bioworks

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Ginkgo Bioworks frequently co-invest with?

Which angels does Ginkgo Bioworks often collaborate with?

What are some of recent deals done by Ginkgo Bioworks?

Ready to Raise Capital?

Pages

Free tools